Literature DB >> 17334345

Prognostic significance of angiogenesis in gastrointestinal stromal tumor.

Masakazu Imamura1, Hidetaka Yamamoto, Norimoto Nakamura, Yoshinao Oda, Takashi Yao, Yoshihiro Kakeji, Hideo Baba, Yoshihiko Maehara, Masazumi Tsuneyoshi.   

Abstract

Angiogenesis is important in the growth and metastasis of various kinds of solid tumors. To investigate the potential role of angiogenesis in gastrointestinal stromal tumor (GIST), an immunohistochemical analysis was performed in 95 cases of GISTs for microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression. MVD was evaluated with immunohistochemical staining for CD31. A high level of MVD was significantly correlated with overexpression of VEGF, tumor location (intestine>stomach), tumor size (> or =5 cm), tumor grade (high>intermediate>low grade) (P=<0.0001, 0.0422, 0.0006, 0.0359, respectively). Of the 70 GISTs analyzed, KIT exon 11 mutations were detected in 45 cases (64.3%) and KIT exon 9 mutations in two cases (2.9%). No mutations were found in KIT exons 13 and 17, and platelet-derived growth factor receptor-alpha exons 12 and 18. Interestingly, VEGF expression level was significantly higher in the non-KIT exon 11 mutant group than in the KIT exon 11 mutant group (P=0.0266). In univariate analysis, tumor grade (high grade), tumor size (> or =5 cm), mitotic count (> or =5/50 high-power fields), Ki-67 labeling index (> or =4.6%), MVD (> or =7.0/0.95 mm(2)) and VEGF expression (high) were significantly associated with a shorter period of disease-free survival (P=<0.0001, 0.0199, 0.0055 0.0027, 0.0028 and 0.0302, respectively). In multivariate analysis, tumor grade and MVD were identified as independent worse prognostic factors (P=0.0007, 0.0152, respectively). In conclusion, our results suggest that the evaluation of MVD and VEGF expression is useful for predicting the aggressive biologic behavior of GIST, and that angiogenesis associated with VEGF may play an important role, at least in part, in the progression of GIST.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334345     DOI: 10.1038/modpathol.3800767

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  22 in total

1.  Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors.

Authors:  Noah A Cohen; Shan Zeng; Adrian M Seifert; Teresa S Kim; Eric C Sorenson; Jonathan B Greer; Michael J Beckman; Juan A Santamaria-Barria; Megan H Crawley; Benjamin L Green; Ferdinand Rossi; Peter Besmer; Cristina R Antonescu; Ronald P DeMatteo
Journal:  Cancer Res       Date:  2015-04-02       Impact factor: 12.701

Review 2.  Molecular response prediction in gastrointestinal stromal tumors.

Authors:  Philippe A Cassier; Jean-Yves Blay
Journal:  Target Oncol       Date:  2010-04-02       Impact factor: 4.493

3.  The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft.

Authors:  Tian-bao Wang; Xiu-qing Wei; Wei-hao Lin; Han-ping Shi; Wen-guang Dong
Journal:  Clin Exp Med       Date:  2011-06-10       Impact factor: 3.984

4.  Microvascular density and endothelial area correlate with Ki-67 proliferative index in surgically-treated pancreatic ductal adenocarcinoma patients.

Authors:  Michele Ammendola; Rosario Sacco; Ilaria Marech; Giuseppe Sammarco; Valeria Zuccalà; Maria Luposella; Rosa Patruno; Marcella Giordano; Eustachio Ruggieri; Nicola Zizzo; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

5.  Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.

Authors:  Rodrigo Panno Basilio-de-Oliveira; Vera Lucia Nunes Pannain
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

6.  Molecular spectrum of c-KIT and PDGFRA gene mutations in gastro intestinal stromal tumor: determination of frequency, distribution pattern and identification of novel mutations in Indian patients.

Authors:  Firoz Ahmad; Purnima Lad; Simi Bhatia; Bibhu Ranjan Das
Journal:  Med Oncol       Date:  2014-12-07       Impact factor: 3.064

7.  Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer.

Authors:  Xiao-Dong Xie; Shu-Xian Qu; Zhao-Zhe Liu; Fang Zhang; Zhen-Dong Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-30       Impact factor: 4.553

8.  Differential expression of angiogenic factors in peripheral nerve sheath tumors.

Authors:  Junji Wasa; Yoshihiro Nishida; Yoshitaka Suzuki; Satoshi Tsukushi; Yoji Shido; Kozo Hosono; Yoshie Shimoyama; Shigeo Nakamura; Naoki Ishiguro
Journal:  Clin Exp Metastasis       Date:  2008-08-05       Impact factor: 5.150

9.  Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.

Authors:  Midori Toda-Ishii; Keisuke Akaike; Yoshiyuki Suehara; Kenta Mukaihara; Daisuke Kubota; Shinji Kohsaka; Taketo Okubo; Keiko Mitani; Kaoru Mogushi; Tatsuya Takagi; Kazuo Kaneko; Takashi Yao; Tsuyoshi Saito
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

10.  Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors.

Authors:  T B Wang; W S Qiu; B Wei; M H Deng; H B Wei; W G Dong
Journal:  Ir J Med Sci       Date:  2009-04-15       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.